Biotest

Biotest, a company founded in 1946, operates within the Pharmaceuticals and Healthcare industries. Its headquarters are situated in Hesse, Germany, from where it directs its specialized operations. The company's primary focus lies in the development, production, and distribution of biopharmaceutical products essential for hematology, clinical immunology, and intensive care units, addressing critical patient needs across these medical fields.

With a substantial operational footprint, Biotest employs between 1,000 and 5,000 individuals across its 6 global locations. The company's product portfolio is centered on plasma-derived therapeutics, including vital components like albumin and various human blood plasma derivatives, alongside other biopharmaceutical proteins. These products are crucial for a range of medical applications. To gain insight into the leadership and personnel driving these advancements, one can Meet Biotest's team.

Biotest generates significant revenue, reported at $871.9M, underscoring its robust market position. Traded under the ticker FRA: BIO, the company has a strong presence, particularly within the European market, contributing to advancements in biological drug development. Its long-standing history since 1946, coupled with its specialized focus on therapeutic proteins and biopharmaceuticals, solidifies its role as a key entity in the global healthcare landscape.